Besides, biology assay is needed to identify the proliferative and metabolism pathways and downstream targets susceptible to the two TFs, so as to uncover the underlying mechanism of the TF signature to the disease progression and patient survival in HCC. This evidence concerns the gene TF and hepatocellular carcinoma.